SCHEMBL5331622

SCHEMBL5331622

O=C(NCc1cccc(Cl)c1)c1ccc2ncccc2c1

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.62
MAPK1 P28482 2/20 0.62
KDM4E B2RXH2 1/20 0.62
ALDH1A1 P00352 1/20 0.62
MAPT P10636 1/20 0.62
RAB9A P51151 1/20 0.62
NPC1 O15118 1/20 0.61
POLB P06746 1/20 0.56
PLK1 P53350 1/20 0.55
EGLN1 Q9GZT9 1/20 0.55
THRB P10828 1/20 0.53
DOT1L Q8TEK3 1/20 0.53
MAPK3 P27361 1/20 0.53
MAOB P27338 1/20 0.51
MEN1 O00255 1/20 0.50
HCRTR1 O43613 1/20 0.50
KMT2A Q03164 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1680446 0.89 RAB9A (0.63) LMNAMAPK1KDM4EALDH1A1MAPT
SCHEMBL13491677 0.88 POLB (0.60) LMNARAB9ANPC1POLBPLK1
SCHEMBL1680798 0.87 ROCK2 (0.59) LMNAMAPK1KDM4EALDH1A1MAPT
SCHEMBL1680916 0.86 LMNA (0.51) LMNAMAPK1KDM4EALDH1A1MAPT
SCHEMBL3213042 0.86 PLK1 (0.62) ALDH1A1MAPTRAB9APLK1EGLN1
SCHEMBL13491369 0.86 EGLN1 (0.67) LMNAPLK1EGLN1THRBMAOB
SCHEMBL13804470 0.86 PLK1 (0.59) LMNAMAPK1KDM4EALDH1A1MAPT
SCHEMBL13491381 0.86 PLK1 (0.55) LMNAMAPK1KDM4EALDH1A1MAPT
SCHEMBL1680284 0.86 LMNA (0.64) LMNAMAPK1KDM4EALDH1A1MAPT
SCHEMBL1681275 0.85 PLK1 (0.57) ALDH1A1MAPTRAB9APLK1EGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007138112-A2 COMPOUNDS THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE KV FAMILY DEVGEN N.V. (BE) 2007-12-06 WO claimed
US-20100041694-A1 AGRICULTURAL COMPOSITION FOR CONTROLLING OR PREVENTING PLANT DISEASES CAUSED BY PLANT PATHOGENIC MICROBES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-02-18 US disclosed
US-20100041694-A1 AGRICULTURAL COMPOSITION FOR CONTROLLING OR PREVENTING PLANT DISEASES CAUSED BY PLANT PATHOGENIC MICROBES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-02-18 US disclosed
WO-2007138112-A2 COMPOUNDS THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE KV FAMILY DEVGEN N.V. (BE) 2007-12-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041694-A1 AGRICULTURAL COMPOSITION FOR CONTROLLING OR PREVENTING PLANT DISEASES CAUSED BY PLANT PATHOGENIC MICROBES HDHD5, NAAA, BROX LMNA 3240/4885MAPK1 2539/4885KDM4E 2045/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.